Yeung C Y
Arch Dis Child. 1972 Apr;47(252):246-9. doi: 10.1136/adc.47.252.246.
A controlled study was carried out to show the effect of bilirubinaemia and phenobarbitone therapy on the blood sugar metabolism in newborn infants. In the control infants, a significant inverse correlation existed between the serum bilirubin and the blood sugar levels in the first 4 days. The liver seemed to be a factor in producing such a relation. Glucose may be a useful adjunct to the treatment of neonatal hyperbilirubinaemia. Phenobarbitone therapy had significantly raised the blood sugar levels and lowered the serum bilirubin levels in these infants. It is suggested that enhancement of liver function or induction of hepatic enzymes may be the cause.
开展了一项对照研究,以显示胆红素血症和苯巴比妥治疗对新生儿血糖代谢的影响。在对照婴儿中,头4天血清胆红素与血糖水平之间存在显著的负相关。肝脏似乎是产生这种关系的一个因素。葡萄糖可能是治疗新生儿高胆红素血症的有用辅助药物。苯巴比妥治疗显著提高了这些婴儿的血糖水平并降低了血清胆红素水平。提示肝功能增强或肝酶诱导可能是其原因。